MetLife, Inc. (NYSE:MET) Shares Purchased by Joel Isaacson & Co. LLC

Joel Isaacson & Co. LLC boosted its position in MetLife, Inc. (NYSE:METFree Report) by 108.4% during the fourth quarter, Holdings Channel.com reports. The fund owned 10,445 shares of the financial services provider’s stock after purchasing an additional 5,433 shares during the quarter. Joel Isaacson & Co. LLC’s holdings in MetLife were worth $855,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the company. Swedbank AB increased its holdings in MetLife by 76.0% in the fourth quarter. Swedbank AB now owns 3,466,808 shares of the financial services provider’s stock valued at $283,862,000 after buying an additional 1,496,645 shares during the last quarter. Zurich Insurance Group Ltd FI bought a new stake in MetLife during the third quarter valued at $91,771,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. raised its holdings in shares of MetLife by 79.1% during the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,726,209 shares of the financial services provider’s stock worth $142,378,000 after purchasing an additional 762,291 shares during the period. Jacobs Levy Equity Management Inc. lifted its position in shares of MetLife by 256.6% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 948,223 shares of the financial services provider’s stock worth $78,209,000 after buying an additional 682,333 shares during the last quarter. Finally, Nordea Investment Management AB boosted its holdings in shares of MetLife by 16.8% in the 4th quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock valued at $347,735,000 after buying an additional 608,224 shares during the period. Hedge funds and other institutional investors own 94.99% of the company’s stock.

MetLife Stock Up 0.4 %

MET stock opened at $83.99 on Friday. The firm has a market cap of $58.16 billion, a PE ratio of 16.93, a P/E/G ratio of 0.66 and a beta of 1.07. MetLife, Inc. has a 12 month low of $66.18 and a 12 month high of $89.05. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The firm has a 50 day simple moving average of $83.80 and a 200 day simple moving average of $80.73.

MetLife (NYSE:METGet Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a net margin of 5.27% and a return on equity of 20.01%. Equities research analysts forecast that MetLife, Inc. will post 8.18 earnings per share for the current fiscal year.

MetLife Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be paid a $0.545 dividend. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a yield of 2.60%. MetLife’s dividend payout ratio is currently 36.52%.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on MET shares. StockNews.com cut MetLife from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Barclays reduced their price target on shares of MetLife from $96.00 to $95.00 and set an “overweight” rating for the company in a report on Friday. BMO Capital Markets initiated coverage on shares of MetLife in a report on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 price objective on the stock. JPMorgan Chase & Co. boosted their target price on shares of MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Finally, Wells Fargo & Company dropped their price target on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 14th. Two investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat.com, MetLife currently has an average rating of “Moderate Buy” and a consensus price target of $91.08.

Read Our Latest Report on MetLife

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

See Also

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.